Concepedia

Ryoji Ishida

RI

Statistics

Publications

36

Citations

2.4K

H-Index

22

Active since

1974

Affiliations

Aichi Cancer Center(Current)

Gifu Pharmaceutical University

Tokyo Medical University

Medical & Biological Laboratories (Japan)

Mitsubishi Group (Japan)

Ryoji Ishida is an author at Aichi Cancer Center specializing in molecular biology, life sciences, and cancer pharmacology.

Publications per year

1974–2008

36

Publications

36

Antitumor bisdioxopiperazines inhibit yeast DNAtopoisomerase II by trapping the enzyme in the form of a closed proteinclamp.

Joaquím Roca, Ryoji Ishida, James M. Berger et al. · Proceedings of the National Academy of Sciences · 1994 · 354 citations · Full text

Medicine, Molecular Biology, Pharmacology +12

Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives.

K Tanabe, Yoji Ikegami, Ryoji Ishida et al. · PubMed · 1991 · 297 citations

Medicine, Medicinal Chemistry, Pharmacology +10

Susceptibility of Fanconi's anemia lymphoblasts to DNA-cross-linking and alkylating agents.

Ryoji Ishida, Manuel Buchwald · PubMed · 1982 · 201 citations

Pharmacy, Genetics, Toxicology +17

Inhibition of intracellular topoisomerase II by antitumor bis(2,6-dioxopiperazine) derivatives: mode of cell growth inhibition distinct from that of cleavable complex-forming type inhibitors.

Ryoji Ishida, T Miki, Toshiharu Narita et al. · PubMed · 1991 · 195 citations

Medicine, Oncology, Pharmacology +13

Increased DNA chain breakage by combined action of bleomycin and superoxide radical

Ryoji Ishida, Taijo Takahashi · Biochemical and Biophysical Research Communications · 1975 · 184 citations

Life Sciences, Cell Biology, Molecular Biology +13

1–5 of 36